Chlorpromazine Hydrochloride Tablet, Film Coated
Product Images NDC 0832-6021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 0832-6021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mg Tablet Bottle Label)
This is a description of Hydrochloride Tablets. Each tablet contains chorproMAZINE HCl, USP 10 mg. The usual dosage is stated in the prescribing information. The tablets come in a package that should be stored at a temperature of 20 ° to 25 °C (68 ° to 77 °F), with permitted excursions to 15°-30°C (59° to 86°F). The package should be protected from light and moisture. This medication is for outpatient use only, and the package is not for household dispensing. The manufacturing is done by Upsher-Smith Laboratories, LLC. It is important to keep the product away from children.*
Principal Display Panel (25 mg Tablet Bottle Label)
TG YAL Hydrochloride Tablets, USP are a prescription medicine that contain chiorpromazine hydrochloride in a strength of 25 mg per tablet. The usual dosage of these tablets is mentioned in the prescribing information. The tablets should be stored between 20°C and 25°C, with excursions allowed up to 30°C, and protected from light and moisture. These tablets are not meant for household dispensing and should be kept out of reach of children. The package has been sealed for protection and is manufactured by Upsher-Smith Laboratories, LLC located in Maple Grove, MN. The copyright for the package belongs to Upsher-Smith Laboratories and the revision date of the package is September 1, 2020.*
Principal Display Panel (50 mg Tablet Bottle Label)
This is a prescription drug called LTI YAL S Hydrochloride Tablets, USP which contains 50 mg of chiorpromazine HC1, USP. The dosage information can be found in the Prescribing Information. It comes in a package of 100 tablets and should be stored at a controlled temperature with protection from light and moisture. This package is not for household dispensing and should be kept out of the reach of children. Manufactured by Upsher-Smith Laboratories, LLC in Maple Grove, MN in 2020.*
Principal Display Panel (100 mg Tablet Bottle Label)
This is a description of Chlorpromazine Hydrochloride Tablets, USP, which come in a package containing 100 tablets. Each tablet contains 100 mg of Chlorpromazine HC, USP, and is intended for use only in severe neuropsychiatric conditions under prescription. The typical dosage information is available upon prescription. The tablets should be stored in a dry, cool environment, and should be kept out of reach of children. The package is not intended for household purposes, but rather for outpatient use, so the container should be child-resistant and light-resistant. The manufacturer is Upsher-Smith Laboratories, based in Maple Grove, Minnesota. This description is suitable for those who need information on Chlorpromazine Hydrochloride Tablets, USP.*
Principal Display Panel (200 mg Tablet Bottle Label)
This is a description of a medication called Chlorpromazine Hydrochloride with a strength of 200 mg per tablet. It comes in a pack of 100 tablets and requires a prescription for use only in severe neuropsychiatric conditions. The usual dosage information can be obtained from the prescribing doctor. It should be stored in a cool and dry place, away from moisture and sunlight, and should be kept in a child-resistant container. This medication is manufactured by Upsher-Smith Laboratories, LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.